Coronary endothelial dysfunction and myocardial cell damage in chronic stable idiopathic dilated cardiomyopathy

International Journal of Cardiology

Volumn 82, Issue 3, 2002, Pages 237-245

  Martí, Vicens ^a   Aymat, Rosa ^a   Ballester, Manel ^a   García, Joan ^a   Carrió, Ignasi ^a   Augé, Josep M ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Dilated cardiomyopathy; Endothelial dysfunction; Monoclonal antimyosin antibodies

Indexed keywords

ACETYLCHOLINE; DIOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INDIUM 111; MONOCLONAL ANTIBODY; MYOSIN ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; ENDOTHELIUM INJURY; FEMALE; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEMODYNAMICS; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PRIORITY JOURNAL; PROTEIN TRANSPORT; VASOMOTOR REFLEX;

ANTIBODIES, MONOCLONAL; CARDIOMYOPATHY, DILATED; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; HEART; HEMODYNAMIC PROCESSES; HUMANS; INDIUM RADIOISOTOPES; MALE; MIDDLE AGED; MYOCARDIUM; ORGANOMETALLIC COMPOUNDS;

EID: 0036129556     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00003-7     Document Type: Article

References (55)

1. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
2. Regulatory functions of the vascular endothelium
3. Role of endothelium in responses of vascular smooth muscle
4. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries
5. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension
6. Endothelium-mediated coronary blood flow modulations in humans: Effects of age, atherosclerosis, hypercholesterolemia, and hypertension
7. Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries
8. Influence of smoking status on progression of endothelial function
9. Impaired endothelium-dependent and -independent vasodilatation in patients with type 2 (non-insulin-dependent) diabetes mellitus
10. Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries
11. Coronary dilatory capacity in idiopathic dilated cardiomyopathy: Analysis of 16 patients
12. Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomyopathy
13. Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain
14. Endothelium-dependent dilatation of the coronary microvasculature is impaired in dilated cardiomyopathy
15. The effects of intracoronary substance P and acetylcholine on coronary blood flow in patients with idiopathic dilated cardiomyopathy
16. Vasodilatory capacity of coronary resistance vessels in dilated cardiomyopathy
17. Evidence of endothelial dysfunction of epicardial coronary arteries in patients with immunohistochemical proven myocarditis
18. Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy
19. Altered coronary endothelial function in a patient with asymptomatic left ventricular dysfunction
20. Microvascular spasm in the cardiomyopathic Syrian hamster: A preventable cause of focal myocardial necrosis
21. The pathogenesis of clinical and experimental congestive cardiomyopathies: Recent concepts
22. Inhomogenous capillary flow and its prevention by verapamil and hydralazine in the cardiomyopathic Syrian hamster
23. Antimyosin antibody cardiac imaging: Its role in the diagnosis of myocarditis
24. Indium 111-monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis
25. Diagnostic accuracy of antimyosin scintigraphy in suspected myocarditis
26. Specifity of localization of myosin-specific fragments in experimental myocardial infarction: Histologic, histochemical, autoradiographic and scintigraphic studies
27. 111 Indium-antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection
28. Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody
29. 111-Indium antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer
30. Non-invasive detection of human cardiac transplant rejection with In-111 antimyosin (Fab) imaging
31. 111 In-monoclonal antimyosin antibody studies after the first year of heart transplantation: Identification of risk groups for developing rejection during long-term follow-up and clinical implications
32. High prevalence of myocardial monoclonal antimyosin antibody uptake in patients with chronic idiopathic dilated cardiomyopathy
33. Prognostic significance of Indium-111 antimyosin antibody uptake in patients with dilated and hypertrophic cardiomyopathy
34. Role of 111-In-Monoclonal antimyosin antibodies in risk stratification of patients with dilated cardiomyopathy referred for heart transplantation
35. Spectrum of alcohol-induced myocardial damage detected by Indium-111-labeled monoclonal antimyosin antibodies
36. Evaluation of myocardial cell damage by In-111-monoclonal antimyosin antibodies in patients under chronic tricyclic antidepressant drug treatment
37. Myocardial damage does not occur in untreated hyperthyroidism unless associated with congestive heart failure
38. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method
39. Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography
40. Myocardial indium-111 antimyosin uptake in patients with idiopathic dilated cardiomyopathy: Its relation to haemodynamics, histomorphometry, myocardial enteroviral infection, and clinical course
41. Presence, evolving changes, and prognostic implications of myocardial damage detected in idiopathic and alcoholic dilated cardiomyopathy by 111-In monoclonal antimyosin antibodies
42. Viral myocarditis: A paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy
43. Virus infection of endothelial cells
44. Visualization of enteroviral replication in myocardial tissue by ultrastructural in situ hybridization: Identification of target cell and cytopathic effects
45. Cytomegalovirus infection of rat cells in vitro
46. Infection of endothelial cells by common human viruses
47. Immune mechanisms of cardiac disease
48. Coxsackie B-3. Acute and chronic forms of the disease by different immunopathogenic mechanisms
49. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy
50. Immune response to the endothelium in myocarditis, dilated cardiomyopathy and rejection after heart transplantation
51. Immunologic dialogue between cardiac myocites, endothelial cells and mononuclear cells
52. Mechanism and significance of myocardial uptake of antimyosin antibody in myocarditis and cardiomyopathy: Clinical and experimental studies
53. Endothelium-dependent vasodilation is attenuated in patients with heart failure
54. Impaired endothelium-mediated vasodilatation in the peripheral vasculature of patients with congestive heart failure
55. Role of the vascular endothelium in patients with angina pectoris or acute myocardial infarction with normal coronary arteries